Key result
Primary cardiac hypertrophy abrogated the intrinsic resistance of female hearts to ischemia-reperfusion injury, reducing post-ischemic functional recovery from 95.0% in normal rats to 29.0%.
Why the study?
Does primary cardiac hypertrophy abrogate the intrinsic resistance of female hearts to ischemia-reperfusion injury in a rat model?
Does primary cardiac hypertrophy abrogate the intrinsic resistance of female hearts to ischemia-reperfusion injury in a rat model?
Primary genetic cardiac hypertrophy abrogates the intrinsic cardioprotective resistance of female hearts to ischemia-reperfusion injury, potentially due to the loss of endogenous cardioprotective signaling pathways.
Answers are grounded in this paper and cite their sources.
Hypertrophy overrides female I/R resistance in rats; leaves open relevance to women with hypertrophic cardiomyopathy.
Important sex differences in cardiovascular disease outcomes exist, including conditions of hypertrophic cardiomyopathy and cardiac ischemia. Studies of sex differences in the extent to which load-independent (primary) hypertrophy modulates the response to ischemia-reperfusion (I/R) damage have not been characterized. We have previously described a model of primary genetic cardiac hypertrophy, the hypertrophic heart rat (HHR). In this study the sex differences in HHR cardiac function and responses to I/R [compared to control normal heart rat (NHR)] were investigated ex vivo. The ventricular weight index was markedly increased in HHR female (7.82 +/- 0.49 vs. 4.80 +/- 0.10 mg/g; P < 0.05) and male (5.76 +/- 0.22 vs. 4.62 +/- 0.07 mg/g; P < 0.05) hearts. Female hearts of both strains exhibited a reduced basal contractility compared with strain-matched males [maximum first derivative of pressure (dP/dt(max)): NHR, 4,036 +/- 171 vs. 4,258 +/- 152 mmHg/s; and HHR, 3,974 +/- 160 vs. 4,540 +/- 259 mmHg/s; P < 0.05]. HHR hearts were more susceptible to I/R (I = 25 min, and R = 30 min) injury than NHR hearts (decreased functional recovery, and increased lactate dehydrogenase efflux). Female NHR hearts exhibited a significantly greater recovery (dP/dt(max)) post-I/R relative to male NHR (95.0 +/- 12.2% vs. 60.5 +/- 9.4%), a resistance to postischemic dysfunction not evident in female HHR (29.0 +/- 5.6% vs. 25.9 +/- 6.3%). Ventricular fibrillation was suppressed, and expression levels of Akt and ERK1/2 were selectively elevated in female NHR hearts. Thus the occurrence of load-independent primary cardiac hypertrophy undermines the intrinsic resistance of female hearts to I/R insult, with the observed abrogation of endogenous cardioprotective signaling pathways consistent with a potential mechanistic role in this loss of protection.
No takes yet. Share an insight, caveat, or question.
Bell et al. (2008) studied Primary cardiac hypertrophy and ischemia-reperfusion injury. Primary genetic cardiac hypertrophy (HHR) vs. Normal heart rat (NHR) was evaluated on Recovery of maximum first derivative of pressure (dP/dt(max)) post-ischemia/reperfusion in female hearts. Primary cardiac hypertrophy abrogated the intrinsic resistance of female hearts to ischemia-reperfusion injury, reducing post-ischemic functional recovery from 95.0% in normal rats to 29.0%.
Synapse has enriched 10 related papers. Consider them for comparative context: